GlassScriptPhysician profile
Caitlin Farrell
NPI 1649920752
$994.72
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.18 · 2023: $659 · 2024: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $976.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $187.71 | 2023-2024 | Mounjaro, Jardiance |
| Impulse Dynamics (USA) INC. | $182.86 | 2024 | Optimizer |
| Astrazeneca Pharmaceuticals LP | $166.88 | 2023 | Breztri, Farxiga |
| Novo Nordisk INC | $78.45 | 2023 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $69.18 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.47 | 2023 | Jardiance |
| Exact Sciences Corporation | $50.55 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $38.99 | 2023 | |
| Horizon Therapeutics Plc | $25.34 | 2023 | Krystexxa |
| Esperion Therapeutics, INC. | $24.07 | 2023 | Nexletol |
| Organon LLC | $21.78 | 2023 | Nexplanon |
| Coopersurgical, INC. | $21.53 | 2023 | Paragard T 380a |
| Hologic Sales and Service, LLC | $18.78 | 2024 | Aptima |
| Incyte Corporation | $18.18 | 2022 | |
| Kaleo, INC. | $16.99 | 2023 | Auvi-Q |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $14.96 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Farrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.